Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s15010-021-01666-x http://scihub22266oqcxt.onion/10.1007/s15010-021-01666-x 34319569!8317481!34319569     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infection 2021 ; 49 (6): 1163-1186 Nephropedia Template TP {{tp|p=34319569|t=2021. Long COVID, a comprehensive systematic scoping review |pdf=|usr=}}{{34319569}} gab.com Text Long COVID, a comprehensive systematic scoping review JO: Infection http://www.kidney.de/pget.php?&tw=1&pmid=34319569 #FOAvip PURPOSE: To find out what is known from literature about Long COVID until January 30, 2021. METHODS: We undertook a four-step search with no language restriction. A preliminary search was made to identify the keywords. A search strategy of all electronic databases resulted in 66 eligible studies. A forward and backward search of the references and citations resulted in additional 54 publications. Non-English language articles were translated using Google Translate. We conducted our scoping review based on the PRISMA-ScR Checklist. RESULTS: Of 120 papers, we found only one randomized clinical trial. Of the 67 original studies, 22 were cohort, and 28 were cross-sectional studies. Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. Ten publications focused on imaging studies. The results are also presented extensively in a narrative synthesis in separated sections (nomenclature, diagnosis, pathophysiology, risk factors, signs/symptoms, management). CONCLUSIONS: The controversies in its definition have impaired proper recognition and management. The predominant symptoms were: fatigue, breathlessness, arthralgia, sleep difficulties, and chest pain. Recent reports also point to the risk of long-term sequela with cutaneous, respiratory, cardiovascular, musculoskeletal, mental health, neurologic, and renal involvement in those who survive the acute phase of the illness. Twit Text FOAVip Long COVID, a comprehensive systematic scoping review ????Infection http://www.kidney.de/pget.php?&tw=1&pmid=34319569 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34319569 #FOAvip English Wikipedia <ref>{{Cite pmid|34319569}}</ref> Long COVID, a comprehensive systematic scoping review #MMPMID34319569 Akbarialiabad H; Taghrir MH; Abdollahi A; Ghahramani N; Kumar M; Paydar S; Razani B; Mwangi J; Asadi-Pooya AA; Malekmakan L; Bastani B Infection 2021[Dec]; 49 (6): 1163-1186 PMID34319569show ga PURPOSE: To find out what is known from literature about Long COVID until January 30, 2021. METHODS: We undertook a four-step search with no language restriction. A preliminary search was made to identify the keywords. A search strategy of all electronic databases resulted in 66 eligible studies. A forward and backward search of the references and citations resulted in additional 54 publications. Non-English language articles were translated using Google Translate. We conducted our scoping review based on the PRISMA-ScR Checklist. RESULTS: Of 120 papers, we found only one randomized clinical trial. Of the 67 original studies, 22 were cohort, and 28 were cross-sectional studies. Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. Ten publications focused on imaging studies. The results are also presented extensively in a narrative synthesis in separated sections (nomenclature, diagnosis, pathophysiology, risk factors, signs/symptoms, management). CONCLUSIONS: The controversies in its definition have impaired proper recognition and management. The predominant symptoms were: fatigue, breathlessness, arthralgia, sleep difficulties, and chest pain. Recent reports also point to the risk of long-term sequela with cutaneous, respiratory, cardiovascular, musculoskeletal, mental health, neurologic, and renal involvement in those who survive the acute phase of the illness. |*COVID-19/complications[MESH] |Fatigue[MESH] |Humans[MESH] |Post-Acute COVID-19 Syndrome[MESH] |Randomized Controlled Trials as Topic[MESH]Long COVID, a comprehensive systematic scoping review (epmc).pdf DeepDyve Pubget Overpricing